These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25847545)

  • 21. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
    Dhanani TC; Mantovani EH; Turner JR
    Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.
    McNicholl IR; Gandhi M; Hare CB; Greene M; Pierluissi E
    Pharmacotherapy; 2017 Dec; 37(12):1498-1506. PubMed ID: 29023938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome.
    Van der Linden L; Decoutere L; Walgraeve K; Milisen K; Flamaing J; Spriet I; Tournoy J
    Drugs Aging; 2017 Feb; 34(2):123-133. PubMed ID: 27915457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient views about polypharmacy medication review clinics run by clinical pharmacists in GP practices.
    Snell R; Langran T; Donyai P
    Int J Clin Pharm; 2017 Dec; 39(6):1162-1165. PubMed ID: 29022166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community pharmacists' awareness, identification, and management of prescribing cascades: A cross-sectional survey.
    Dalton K; Callaghan R; O'Sullivan N; McCarthy L
    Res Social Adm Pharm; 2024 Jun; 20(6):102-112. PubMed ID: 38768989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
    Lucas B; Blenkinsopp A
    Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial.
    Messerli M; Blozik E; Vriends N; Hersberger KE
    BMC Health Serv Res; 2016 Apr; 16():145. PubMed ID: 27108410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service.
    Elliott RA; Boyd MJ; Salema NE; Davies J; Barber N; Mehta RL; Tanajewski L; Waring J; Latif A; Gkountouras G; Avery AJ; Chuter A; Craig C
    BMJ Qual Saf; 2016 Oct; 25(10):747-58. PubMed ID: 26647412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy.
    Doucette WR; McDonough RP; Klepser D; McCarthy R
    Clin Ther; 2005 Jul; 27(7):1104-11. PubMed ID: 16154490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial.
    Gillespie U; Alassaad A; Hammarlund-Udenaes M; Mörlin C; Henrohn D; Bertilsson M; Melhus H
    PLoS One; 2013; 8(5):e62401. PubMed ID: 23690938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriateness of Medications in Older Adults Living With Frailty: Impact of a Pharmacist-Led Structured Medication Review Process in Primary Care.
    Khera S; Abbasi M; Dabravolskaj J; Sadowski CA; Yua H; Chevalier B
    J Prim Care Community Health; 2019; 10():2150132719890227. PubMed ID: 31808725
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of prescribing in community-dwelling elderly patients in France: an observational study in community pharmacies.
    Bourcier E; Mille F; Brunie V; Korb-Savoldelli V; Lafortune C; Buyse M; Fernandez C; Hindlet P
    Int J Clin Pharm; 2017 Dec; 39(6):1220-1227. PubMed ID: 28905162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Columbus Air Force Base medication profile intervention practice innovation.
    Guill JV; Griffin LA; Goodwin TD
    J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
    Nusair MB; Guirguis LM
    Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.
    Modig S; Holmdahl L; Bondesson Å
    Int J Clin Pharm; 2016 Feb; 38(1):41-5. PubMed ID: 26582483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study.
    Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Turner D; Zermansky A; Wright D;
    Trials; 2020 Jan; 21(1):103. PubMed ID: 31964398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of a community pharmacy-based falls prevention program.
    Casteel C; Blalock SJ; Ferreri S; Roth MT; Demby KB
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):310-9.e2. PubMed ID: 21925959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.